Viral and mycoplasma pneumonias.
D000547:Amantadine / Q000009:adverse effects / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002644:Chickenpox / Q000150:complications; D006801:Humans; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000150:complications / Q000517:prevention & control; D009175:Mycoplasma Infections / Q000175:diagnosis / Q000188:drug therapy; D011014:Pneumonia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D011024:Pneumonia, Viral / Q000145:classification* / Q000175:diagnosis / Q000188:drug therapy; D014611:Vaccination
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D007252:Influenza Vaccines; D000547:Amantadine